Parnayavani swarasa as an adjuvant in the management of Sheetapitta w.s.r to Urticaria
Phase 3
- Conditions
- Health Condition 1: L509- Urticaria, unspecified
- Registration Number
- CTRI/2023/06/053565
- Lead Sponsor
- SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients showing minimum of 3 classical clinical feature of Sheetapitta.
2.Patients of age group between 21 to 60 years will be included irrespective of their gender, religion, marital status and socioeconomical status.
3.Subjects who are willing to participate in the study by giving the written consent
Exclusion Criteria
1.Patients having associative symptoms like vomiting, fever and suffering from any other infections or systemic disorders.
2.History of angioedema and other skin disease like psoriasis, eczema.
3.History of anaphylaxis to medicine.
4.Subjects who are pregnant and lactating.
5.Subjects who are not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreased symptoms of Urticarial rashesTimepoint: 0th, 14th, 20th day
- Secondary Outcome Measures
Name Time Method Reduction in AEC countTimepoint: 0th, 14th, 20th day